Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
VERO 
Venus Concept Inc (VERO)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/27/2025: VERO (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $10.6
1 Year Target Price $10.6
| 0 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -79.37% | Avg. Invested days 18 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/27/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 4.05M USD | Price to earnings Ratio - | 1Y Target Price 10.6 |
Price to earnings Ratio - | 1Y Target Price 10.6 | ||
Volume (30-day avg) 1 | Beta 0.06 | 52 Weeks Range 2.10 - 11.87 | Updated Date 06/30/2025 |
52 Weeks Range 2.10 - 11.87 | Updated Date 06/30/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -71.73 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -81.26% | Operating Margin (TTM) -69.84% |
Management Effectiveness
Return on Assets (TTM) -24.36% | Return on Equity (TTM) -463.54% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 39376114 | Price to Sales(TTM) 0.07 |
Enterprise Value 39376114 | Price to Sales(TTM) 0.07 | ||
Enterprise Value to Revenue 0.65 | Enterprise Value to EBITDA -3.16 | Shares Outstanding 1859120 | Shares Floating 1110664 |
Shares Outstanding 1859120 | Shares Floating 1110664 | ||
Percent Insiders 0.82 | Percent Institutions 15.49 |
Analyst Ratings
Rating 1 | Target Price 10.6 | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold 1 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Venus Concept Inc
Company Overview
History and Background
Venus Concept Inc. was founded in 2009. It designs, commercializes, and delivers minimally invasive medical aesthetic technologies and procedures. The company has expanded its global presence through direct sales and distributors.
Core Business Areas
- Aesthetic Devices: This segment develops, commercializes, and services medical aesthetic devices used for non-invasive and minimally invasive aesthetic procedures such as skin tightening, body contouring, and hair removal.
- Consumables and Services: This segment sells consumables used with the devices and provides service and support to its customers.
Leadership and Structure
The leadership team includes Rajiv De Silva (CEO) and various other executives leading finance, operations, and marketing. The company operates with a functional organizational structure, with departments focusing on specific areas like R&D, sales, and marketing.
Top Products and Market Share
Key Offerings
- Venus Versa: A multi-application platform that delivers a wide range of non-invasive aesthetic procedures. Competitors include Cynosure (CYNO) and Lumenis. No specific market share data available but its a leading product in multi-application devices.
- Venus Velocity: A diode laser for hair removal, offering speed and comfort. Competitors include Candela and Cutera. No specific market share data available but is a competive offering.
- Venus Viva: Fractional radio frequency system for skin resurfacing and rejuvenation. Competitors include Solta Medical and Alma Lasers. No specific market share data available but is a competive offering.
Market Dynamics
Industry Overview
The medical aesthetics market is experiencing growth due to increasing demand for non-invasive and minimally invasive procedures, technological advancements, and an aging population seeking cosmetic enhancements.
Positioning
Venus Concept Inc. positions itself as an innovative provider of medical aesthetic solutions with a focus on multi-application platforms and cost-effective technologies. They compete with established players and emerging companies.
Total Addressable Market (TAM)
The global medical aesthetics market is projected to reach hundreds of billions of USD in the coming years. Venus Concept Inc. is positioned to capture a portion of this market through its product offerings and market expansion.
Upturn SWOT Analysis
Strengths
- Diverse product portfolio
- Global presence and distribution network
- Innovative technology and solutions
- Focus on cost-effectiveness
Weaknesses
- Limited financial resources compared to larger competitors
- High operating expenses
- Dependence on third-party distributors in some regions
- Variable product quality
Opportunities
- Expanding product lines with new technologies
- Penetrating emerging markets
- Increasing demand for non-invasive procedures
- Strategic partnerships and acquisitions
Threats
- Intense competition from larger players
- Technological advancements rendering existing products obsolete
- Economic downturn affecting consumer spending
- Regulatory changes and compliance requirements
Competitors and Market Share
Key Competitors
- CYNO
- LMNR
- ALMA
- CUTI
Competitive Landscape
Venus Concept Inc. faces a competitive landscape with larger, well-established companies. It differentiates itself through innovation and cost-effectiveness but must continue to invest in R&D and marketing.
Growth Trajectory and Initiatives
Historical Growth: Information not available
Future Projections: Information not available
Recent Initiatives: Information not available
Summary
Venus Concept Inc. is a player in the competitive medical aesthetics market, offering a diverse range of products. Its strengths lie in its innovative solutions and global reach. However, it faces challenges from larger competitors and needs to improve its financial performance. Strategic initiatives focused on product development and market expansion are crucial for future growth.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Industry Reports
- Analyst Reports
Disclaimers:
The information provided is for informational purposes only and should not be considered financial advice. Market share data is estimated and may not be precise. Financial information and performance may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Venus Concept Inc
Exchange NASDAQ | Headquaters Toronto, ON, Canada | ||
IPO Launch date 2012-11-05 | CEO & Director Mr. Rajiv Kanishka Liyanaarchchie De Silva | ||
Sector Healthcare | Industry Medical Devices | Full time employees 292 | Website https://www.venus.ai |
Full time employees 292 | Website https://www.venus.ai | ||
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, a portable and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF combined with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, flanks, back, and thighs in individuals with a body mass index BMI of 30 or less; Venus Glow, a Motorized dermabrasion device used to improve skin appearance; and NeoGraft, a hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.